Search results
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 1 day agoSince then, the stock has trended lower. The vaccine is based on protein technology,...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 1 day agoHowever, he adds that we still don’t have great treatments for COVID, with Paxlovid being the only ...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 5 days agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
COVID-flu combination vaccine shows positive results in late-stage trial, Moderna says
WPTZ Burlington· 5 days agoCalling the outcome of the late-stage trial “breakthrough results,” Moderna’s Chief Medical Affairs...
Moderna's combo COVID and flu shot offers strong immunity in older adults during late stage trial
KABC 7 Los Angeles· 5 days agoModerna's combo flu and COVID vaccine provided a strong immune response in older adults, with levels comparable to getting the flu and COVID< ...
CyanVac secures funding for Phase IIb intranasal Covid-19 vaccine trial
Clinical Trials Arena via Yahoo Finance· 19 hours agoThe double-blinded, randomised trial will compare CVXGA's efficacy, safety, and immunogenicity...
Combo COVID/flu vaccine elicits higher immune response in trial
United Press International via Yahoo News· 5 days agoAn experimental vaccine that could offer one-stop prevention for both COVID-19 and influenza is...
Moderna president: Company outlook 'stabilizing' thanks to new flu-COVID vaccine data
Yahoo Finance via AOL· 4 days agoModerna (MRNA) is on its way to getting a third mRNA-based vaccine approved by the FDA if the...
US government to fund up to $500 million for studies on oral, nasal COVID vaccines By Reuters
Investing.com· 1 day agoThe funding is part of Project NextGen, a $5 billion initiative led by the Biomedical Advanced...
Moderna Says Combination Flu And Covid Vaccine Beat Out Rivals From Sanofi, GSK
Investor's Business Daily· 4 days agoNotably, the side effects were generally low-grade and consistent...in the study. Mock noted the...